National Council for Behavioral Health

Skip to content
Find a Provider
The National Council logo
Capitol Connector
Your source for the latest updates from Capitol Hill. We translate policy into practice so you can learn how policy trends will affect your work and how best to prepare.

Michael Petruzzelli

, National Council for Behavioral Health

Trump Taps Nominee for Asst. Secretary of Mental Health and Substance Use

April 27, 2017 | Uncategorized | Comments
Share on LinkedIn
Featured image of the post

President Trump announced this week his pick for the first-ever Assistant Secretary of the Mental Health and Substance Use. Dr. Elinore McCance-Katz, currently serving as the Chief Medical Officer for Rhode Island’s Department of Behavioral Healthcare, Developmental Disabilities and Hospitals, served two years under President Obama as the Chief Medical Officer at SAMHSA. Created as a part of the 21st Century Cures Act of 2016, this position must be confirmed by the Senate.

Dr. McCance-Katz has worked in the field of addiction medicine for over 20 years as a clinician, teacher, and clinical researcher. Her specialty areas include pharmacotherapy for substance use disorders, clinical pharmacology of drugs of abuse, drug interactions, cocaine/alcohol/opioid medications development, and co-occurring HIV disease and addiction. Her clinical interests are in the treatment of those with co-occurring substance use disorders, infectious diseases including HIV and Hepatitis C, and mental illness. She is also interested in the treatment of those with chronic pain who have developed problems with opioid analgesic overuse/misuse often with co-occurring mental illness.

Prior to her role as Chief Medical Officer at SAMHSA from 2013-2015, she was the Medical Director of the Physicians’ Clinical Support System for Buprenorphine and the Prescribers’ Clinical Support System for Opioid Therapies. These initiatives were run out of the Center for Substance Abuse Treatment and offered national training and peer support for physicians and clinicians treating patients with clinical need for opioid medications.

Dr. McCance-Katz was a Professor of Psychiatry at the University of California San Francisco and served as the State Medical Director for the California Department of Alcohol and Drug Programs. She is board-certified in General Psychiatry and Addiction Psychiatry and is a Distinguished Fellow of the American Academy of Addiction Psychiatry.